Another metal-on-metal hip replacement component is in litigation news: A case involving a woman alleging the Zimmer M/L Taper with Kinectiv Technology hip implant system with a VerSys femoral head was defectively designed and manufactured is set for trial in a Pennsylvania federal court on July 31.
A growing number of Proton Pump Inhibitor (PPI) lawsuits have been filed against the manufacturers of PPI medications. Plaintiffs allege that as a result of taking a PPI for gastric acid-related conditions, they have been diagnosed with kidney injuries including Acute Interstitial Nephritis (AIN), chronic kidney disease and renal failure.
Originally scheduled to start in February, the first Bellwether trial for the blood thinner, Xarelto, will now begin on April 24, 2017 in the Eastern District of Louisiana.
In October 2016, a panel of federal judges created MDL No. 2741 to centralize dozens of Roundup lawsuits in one federal court, the U.S. District Court for the Northern District of California under Judge Vince Chhabria.
A new study, published in the scientific journal, JAMA Surgical on September 28, 2016, suggests that IVC filters may not help people who are at risk of dangerous blood clots to improve their chances of survival.
Yesterday, a federal jury in Dallas, TX, awarded a record $1 billion verdict against Johnson & Johnson and its DePuy Orthopaedics unit to six plaintiffs injured by the company’s Pinnacle metal-on-metal hip implants.
A little more than a year ago, NBC News aired a 2-part series investigating the safety of IVC filters, alleging that some have high failure and breakage rates causing devastating results.
IVC filters are a small, cage-like device implanted in patients who have an increased risk of developing blood clots and cannot be successfully treated by other methods, such as blood thinners. Unfortunately, these devices have been linked to complications such as migration and perforation of other organs.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has decided to consolidate all pending Abilify cases against Bristol-Myers Squibb and Otsuka Pharmaceuticals. This decision will centralize all cases filed in the federal court system before one judge, the Honorable M. Casey Rodgers in the U.S. District Court for the Northern District of Florida.
